isabelobrien, Author at European Medical Journal - Page 36 of 70

Handshake on a green background

Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal

The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.

ARS' Richard Lowenthal on his mission to transform allergy care

Richard Lowenthal, CEO, ARS Pharmaceuticals, reveals the company’s mission to address unmet needs in allergy care with its new nasal spray.

Gold crown on blue background

HCPs rank pharma in top sectors for trust, says Ipsos

Healthcare professionals’ trust in the pharmaceutical industry has risen since 2020, with many doctors and nurses now expressing high trust.

Christ Toth, CEO, Vantive on a blue and yellow background

5 minutes with... Chris Toth, CEO, Vantive

The former Baxter leader talks about the founding of Vantive, the challenges facing kidney patients, improving access to dialysis and more.

sad woman crouching with a helping hand

Boehringer pledges $5m to WHO Foundation mental health initiative

Discover how this partnership could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations in the Americas.

Martina Dempsey Astellas

Astellas’ Martina Dempsey on achieving equal footing for women in pharma

Martina Dempsey, VP of Commercial Strategy and Operations at Astellas Europe, discusses empowering women in the pharmaceutical industry.

Cartoon of London houses of parliament

Britain explores Eli Lilly’s obesity drug to tackle long-term sickness

The British government is set to explore whether Eli Lilly’s weight-loss drug could play a pivotal role in getting people back to work.

Handshake on blue background

Lundbeck to acquire Longboard and potential blockbuster epilepsy drug

Lundbeck will acquire Longboard Pharmaceuticals, aiming to strengthen its portfolio with its potential blockbuster epilepsy treatment.

contract

Thomas J. Fuchs appointed as Lilly's first Chief AI Officer

Eli Lilly and Company appoints their first Chief AI Officer in Thomas J. Fuchs, to spearhead the strategic direction and leadership of AI.

The word spotlight on a blue background

Spotlight: September 2024

Catch up on all the biggest news to hit the pharmaceutical industry this September, including new appointments, mergers and acquisitions, approvals and more.